Both in Biotechnology
LENZ Therapeutics vs Voyager Therapeutics
Over the past year LENZ returned −87.3% and VYGR returned −60.2%; their daily moves had a correlation of 0.22.
LENZ −87.3% VYGR −60.2%Growth of $1, one year, split-adjusted
| Metric | LENZ | VYGR |
|---|---|---|
| Price | $3.55 | $1.83 |
| Market cap | $111.5M | $112.5M |
| Today | +16.39% | +2.53% |
| 1 month | −1.1% | −25.8% |
| 6 months | −60.9% | −53.2% |
| Year to date | −77.8% | −53.6% |
| 1 year | −88.1% | −60.9% |
| Revenue growth (YoY) | +9.7% | −39.1% |
| Gross margin | 94.9% | 100.0% |
| Net margin | −581.8% | −773.2% |
| P/E (TTM) | — | — |
| Price / sales | 5.2× | 3.3× |
| Net cash | $220.0M | $116.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 60.8% |
| Short % of float | 46.7% | 7.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).